CH485851A - Verfahren zur Herstellung von gereinigten inaktivierten Influenzaviruskonzentraten - Google Patents

Verfahren zur Herstellung von gereinigten inaktivierten Influenzaviruskonzentraten

Info

Publication number
CH485851A
CH485851A CH621367A CH621367A CH485851A CH 485851 A CH485851 A CH 485851A CH 621367 A CH621367 A CH 621367A CH 621367 A CH621367 A CH 621367A CH 485851 A CH485851 A CH 485851A
Authority
CH
Switzerland
Prior art keywords
preparation
influenza virus
inactivated influenza
purified inactivated
virus concentrates
Prior art date
Application number
CH621367A
Other languages
English (en)
Inventor
Peter Lampson George
Alan Machlowitz Roy
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH485851A publication Critical patent/CH485851A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH621367A 1966-05-09 1967-05-02 Verfahren zur Herstellung von gereinigten inaktivierten Influenzaviruskonzentraten CH485851A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54838966A 1966-05-09 1966-05-09

Publications (1)

Publication Number Publication Date
CH485851A true CH485851A (de) 1970-02-15

Family

ID=24188651

Family Applications (1)

Application Number Title Priority Date Filing Date
CH621367A CH485851A (de) 1966-05-09 1967-05-02 Verfahren zur Herstellung von gereinigten inaktivierten Influenzaviruskonzentraten

Country Status (5)

Country Link
CH (1) CH485851A (de)
DE (1) DE1617635C2 (de)
FR (1) FR1605532A (de)
GB (1) GB1131993A (de)
NL (1) NL6706476A (de)

Also Published As

Publication number Publication date
DE1617635B1 (de) 1970-12-23
FR1605532A (en) 1979-02-23
DE1617635C2 (de) 1978-08-24
GB1131993A (en) 1968-10-30
NL6706476A (de) 1967-11-10

Similar Documents

Publication Publication Date Title
CH487916A (de) Verfahren zur Herstellung von 2-Cycloalkylamino-oxazolinen
CH484108A (de) Verfahren zur Herstellung von Pyrrylaminoäthanolen
CH490294A (de) Verfahren zur Herstellung von 3-Methylpentenen
CH485731A (de) Verfahren zur Herstellung von 3-Amino-4-carboxamidopyrazol
AT259760B (de) Verfahren zur Herstellung von Influenzavaccinen
CH484016A (de) Verfahren zur Herstellung von Hydrindacenen
CH479626A (de) Verfahren zur Herstellung von Organooxysilanen
CH491064A (de) Verfahren zur Herstellung von Diaceton-L-sorbose
CH485851A (de) Verfahren zur Herstellung von gereinigten inaktivierten Influenzaviruskonzentraten
CH484155A (de) Verfahren zur Herstellung von 6-Amino-uracil-5-carbonamid-N-sulfonamiden
CH491857A (de) Verfahren zur Herstellung von Phenoxyaminoalkanolen
CH487177A (de) Verfahren zur Herstellung von Thiaimidazolidinen
CH433330A (de) Verfahren zur Herstellung von Äthylenimin
CH490358A (de) Verfahren zur Herstellung von 17a-Äthinyl-17B-hydroxysteroiden
CH472381A (de) Verfahren zur Herstellung von Monohalogeno- azeto-azetamiden
AT277957B (de) Verfahren zur Herstellung von Alkenonen
CH487860A (de) Verfahren zur Herstellung von Arylsulfonylsemicarbaziden
CH477470A (de) Verfahren zur Herstellung von Ribofuranosiden
CH490377A (de) Verfahren zur Herstellung von Aminohydrinen
CH495333A (de) Verfahren zur Herstellung von Trihalogenäthylglycinaten
CH506556A (de) Verfahren zur Herstellung von Chinolylmethylpenicillinen
CH509249A (de) Verfahren zur Herstellung von 3-Aminoalkyl-3-arylindanolen-1
CH480435A (de) Verfahren zur Herstellung von N-Demethyl-N-äthyllincomycin C
AT276763B (de) Verfahren zur Herstellung von Polyacyloxamidrazonen
AT269873B (de) Verfahren zur Herstellung von 2-Nitroimidazolen

Legal Events

Date Code Title Description
PL Patent ceased